UK markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
83.38+1.21 (+1.47%)
At close: 4:00PM EST
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
Total revenue
47,347,000
46,840,000
42,294,000
40,122,000
Cost of revenue
13,621,000
14,112,000
13,509,000
12,775,000
Gross profit
33,726,000
32,728,000
28,785,000
27,347,000
Operating expenses
Research development
10,269,000
9,872,000
9,752,000
10,208,000
Selling general and administrative
10,272,000
10,615,000
10,102,000
9,830,000
Total operating expenses
20,541,000
20,487,000
19,854,000
20,038,000
Operating income or loss
13,185,000
12,241,000
8,931,000
7,309,000
Interest expense
843,000
893,000
772,000
754,000
Total other income/expenses net
1,136,000
-158,000
199,000
-419,000
Income before tax
13,575,000
11,464,000
8,701,000
6,521,000
Income tax expense
2,039,000
1,687,000
2,508,000
4,103,000
Income from continuing operations
11,536,000
9,777,000
6,193,000
2,418,000
Net income
11,517,000
9,843,000
6,220,000
2,394,000
Net income available to common shareholders
11,517,000
9,843,000
6,220,000
2,394,000
Basic EPS
-
3.88
2.40
0.95
Diluted EPS
-
3.81
2.32
0.93
Basic average shares
-
2,539,016
2,592,560
2,696,612
Diluted average shares
-
2,580,000
2,679,000
2,748,000
EBITDA
-
16,009,000
13,992,000
11,912,000